The criteria of Durack and Street [3] were used to define HIV-associated FUO: temperature of ú101ЊF on multiple ocinfected individuals [1], but information on its clinical features in the United States is limited. In fact, only 37 cases have been casions; fever of ú4 weeks' duration for outpatients or ú3 days' duration for inpatients, including at least 2 days' incubareported from two U.S. series [1, 2] . In contrast, the information on HIV-associated FUO from Europe is more abundant. Spetion of microbiological cultures; and a diagnosis that remained uncertain after 3 days despite appropriate investigation. Approcific inclusion criteria for FUO in HIV-infected persons [3] were used in one of the U.S. series [1] and in the eight published priate investigation included the following: determination of blood cell counts; liver enzyme tests; urinalysis; chest radiograEuropean series [4 -11]. The European series reports describe 502 cases [4 -11]; five series (344 cases) have been reported phy; performance of cultures of blood and urine; and initial identification of localizing symptoms or specific findings on from Spain [4 -8]. In southwestern Europe, however, the prevalence of diseases that may cause fever in HIV-infected persons, examination. We did not include patients whose diagnoses were discovered after the third day of hospitalization because of a such as infections due to Leishmania species or Mycobacterium tuberculosis, differs from that in the United States [12, 13] . delay in adequate investigation. The method that identified the cause of FUO was recorded; when multiple tests provided the These differences may, as a consequence, affect the spectrum of conditions that cause FUO. Thus, this article describes the diagnosis in an individual case, the one that first identified the etiology was termed the method that yielded the diagnosis. A clinical features of HIV-associated FUO in the United States and reviews the literature on this topic. patient was considered to have a second episode of FUO when at least 4 weeks had passed since the end of the previous fever. Each case-patient in this study was known to be HIV-infected Patients and Methods prior to the onset of the FUO. Data were statistically analyzed and groups of patients were This retrospective study of HIV-associated FUO was conducted at the Brigham and Women's Hospital (Boston) and the compared with use of x 2 analysis. A P value of õ.05 was considered significant. University of Michigan Medical Center (Ann Arbor, Michigan) from January 1992 through January 1997.
Seventy-eight percent of patients were receiving prophy-PCP 10 (13) laxis against Pneumocystis carinii pneumonia (PCP); this CMV 8 (11) consisted of trimethoprim-sulfamethoxazole (40%), dapsone Histoplasmosis 5 (7) Viral (not CMV)* 5 (7) (29%), and aerosolized pentamidine (10%). The patients in Bacterial 4 (5) 33% of cases were receiving rifabutin as prophylaxis against
Mycobacterium tuberculosis 4 (5) disseminated Mycobacterium avium complex (DMAC), and yielded the greatest number of diagnoses; an etiology was idendifferences in the CD4 cell count in relation to the various tified 16 times by this method (22%). Respiratory specimens etiologies of FUO identified. Disease due to DMAC was the led to the diagnosis 18 times; they were obtained noninvasively most common (31%). The percentage of patients with DMAC 7 of the 18 times. Other useful diagnostic methods included infection who were receiving rifabutin as prophylaxis (27%) bone marrow examination (7%) and biopsy of lymph node did not differ statistically from that of patients with an etiology (6%) and liver (6%). Repeated examination or observation of other than MAC infection (35%) or no diagnosis (34%). PCP the clinical course established the diagnosis 5 times (7%); this was noted in 13% of patients. The percentage of patients with method included the recognition of characteristic findings that PCP who were receiving prophylaxis (40%) was statistically first appeared on physical examination late in the course of lower than that of patients with an etiology other than PCP FUO (3 cases) and the observation of the clinical response to (85%) or no diagnosis (71%) (P õ .05). All cases of PCP a change in therapy (2 cases). presented with prolonged undifferentiated fever (mean duration of fever, 16 days) prior to the onset of specific respiratory Discussion symptoms.
Other common diagnoses included cytomegalovirus infecThis case series describes the clinical features of HIV-associated FUO at two medical centers in the United States and tion (11%), disseminated histoplasmosis (7%), and lymphoma proportion of cases of tuberculosis. In addition, leishmaniaNoninvasive radiological procedure 3 (4) sis, a common cause of FUO in European countries, has not Blood smear examination 3 (4) occurred in series in the United States.
Stool culture 1 (1) Regional variations in the prevalence of these infections are tigations for the most common illnesses are justified because multiple etiologies of fever are often present in an individual case. In the United States, Isolator blood culture (the test permits a comparison with previous case series. FUO occurs most often in the late stage of infection; the mean CD4 cell method with the highest yield) for M. avium and Histoplasma capsulatum, analysis of induced sputum for P. carinii and count (per mm 3 ) in this series was 58, whereas it was 160, 74, 94, 56, 60, 46, 40, and 61 in each previous report [4 -11] . In M. tuberculosis, serum cryptococcal antigen testing, and ophthalmologic examination with dilation for cytomegalovirus retiaddition, multiple etiologies are responsible for a significant number of individual cases of FUO -19% in this series and nitis should be considered initially. This approach should not be altered for patients who are receiving prophylaxis against 14% in one previous report [7] . This feature has not been noted in FUO series conducted in the general population [14] .
PCP or DMAC, since a significant proportion of patients in this series with these diagnoses were receiving specific prophylactic Furthermore, infectious diseases, accounting for only 22% -33% of such fevers in the general population [14, 15] , are the agents. In Europe, however, one should consider an early bone marrow examination for signs of leishmaniasis and tuberculopredominant etiology of FUO in HIV-infected persons in the United States and Europe, accounting for 82.2% and 90.6% of sis. In either geographic location, if initial testing is fruitless the approach to FUO in the general population -to guide the cases, respectively (table 3) .
The individual infections accounting for HIV-associated selection of subsequent diagnostic testing, such as biopsy of lung, lymph node, or bone marrow, according to specific exami-FUO in this series in the United States, however, differ markedly from many that have been reported in European nation findings on an individual basis -is also appropriate for HIV-infected persons [14 -16] . countries (table 3). In the United States, DMAC is the single most common cause of HIV-associated FUO, whereas it ocAdditional series studies of HIV-associated FUO in the United States and other countries may help to determine curs less often in Europe. PCP, disseminated histoplasmosis, and infections due to cytomegalovirus are the other infechow the clinical spectrum will be impacted by new therapies, rapid diagnostic tests, and geographic location. First, tions that account for FUO more often in the United States / 9c61$$fe56 01-22-99 12:21:30 cida UC: CID ) 502/46 (9) 186 (37) 61 (12) ** Switzerland [6] ; France [4] ; Spain [5, 7, 9 -11] ; and United Kingdom [8] .
whether the recently observed decrease in AIDS-related illor South America may identify endemic illnesses such as infections due to Coccidioides immitis [24] , Penicillium marneffei nesses causing fever (a decrease resulting from the introduction of the new retroviral protease inhibitors [19] United States may exhibit a larger number of cases of tuberculosis than that reflected in this case series. continue to occur in the 15% -20% of patients treated with protease agents, but no clinically significant elevation in
In the United States, as in Europe, FUO presents in the late stage of HIV infection, and multiple etiologies are involved in CD4 cell counts occurs [19] . The occurrence in this series of FUO in nine patients receiving protease agents who did individual cases. Although infectious diseases are the most common cause of HIV-associated FUO in each location, the not have a significant elevation of CD4 cell counts above the baseline level suggests that FUO may continue to be a spectrum of infections in the United States differs markedly from that in Europe. In the United States, DMAC is the most problem in HIV-infected persons treated with these agents. Second, it is possible that unusual presentations of opportucommon cause of FUO, whereas tuberculosis and leishmaniasis are more often encountered in Europe. An initial evaluation in nistic infections or entirely new conditions may occur in some persons, despite treatment with the new active antivithe United States should include an Isolator blood culture, a sputum evaluation for P. carinii and M. tuberculosis, and other ral agents [20] . Furthermore, rapid tests such as PCR for M. tuberculosis or M. avium or the pp65 serum antigen test noninvasive tests to search for infections due to cytomegalovirus and H. capsulatum. Additional case series are needed to for cytomegalovirus may permit early detection of these infections prior to the onset of FUO [21 -23] .
assess the influence of the new antiretroviral agents and to define the full effect of geographic location on the clinical Finally, additional series studies conducted in the southwestern United States or foreign regions such as southeastern Asia spectrum of HIV-associated FUO.
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